Company: SCYX
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0001140361-25-016641
Chunk: 45

Company: SCYNEXIS INC
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 45
---
730 |     | $128,970 |

| (1) | The amounts in this column reflect the aggregate grant date fair value of the one restricted stock award to acquire 23,000 shares of our common stock granted to each director during the fiscal year, as computed in accordance with the FASB ASC Topic 718. The valuation methodologies and assumptions used in determining such amounts are described in Note 11 to the financial statements included in our Annual Report on Form 10-K as filed on March 12, 2025. The table below lists the aggregate number of shares and additional information with respect to the outstanding option awards held by each of our non-employee directors as of December 31, 2024. |

| (2) | The amounts in this column reflect the aggregate grant date fair value of the one option award to purchase 23,000 shares of our common stock granted to each director during the fiscal year, as computed in accordance with the FASB ASC Topic 718. The valuation methodologies and assumptions used in determining such amounts are described in Note 11 to the financial statements included in our Annual Report on Form 10-K as filed on March 12, 2025. The table below lists the aggregate number of shares and additional information with respect to the outstanding option awards held by each of our non-employee directors as of December 31, 2024. |

Information regarding Dr. Angulo, our Chief Executive Officer, is set forth under “Executive Compensation” above. The following table sets forth information regarding the number of shares of our common stock subject to outstanding restricted stock units and stock options held by our non-employee directors as of December 31, 2024.

| Name                    |     |             Number of Shares 
       Subject to Outstanding 
 Restricted Stock Units as of 
            December 31, 2024 |     |       Number of Shares 
 Subject to Outstanding 
          Options as of 
      December 31, 2024 |
|:------------------------|:----|-----------------------------:|:----|-----------------------:|
| Armando Anido           |     |                       23,000 |     |                 70,000 |
| Steven C. Gilman, Ph.D. |     |                       23,000 |     |                 72,661 |
| Ann F. Hanham, Ph.D.    |     |                       23,000 |     |                 70,661 |
| David Hastings          |     |                       23,000 |